ArticleDiabetology international2027
Baseline monocyte GIP receptor mRNA expression is associated with reductions in body weight and FIB-4 index after switching to tirzepatide in patients with type 2 diabetes.
Hideyuki OkumaPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.